CinCor Pharma, Inc.
CINCNASDAQHealthcare
$29.06
+$0.00(+0.00%)
Market Cap$1.3B
P/E Ratio—
52W High$43.15
52W Low$10.53
CinCor Pharma, Inc. (CINC) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CINC · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Nov 3, 2022EPS Actual
-$0.51
Est. -$0.61 · +16.4%
Revenue
—
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Nov 3, 2022
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
CINC reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q1 FY2023 | Mar 28, 2023 | -$0.55 | — | — | — | — | — |
| ▲ Q4 FY2022 | Nov 3, 2022 | -$0.61 | -$0.51 | +16.4% | — | — | — |
| ▼ Q3 FY2022 | Aug 8, 2022 | -$0.50 | -$0.56 | -12.0% | — | — | — |
| — Q2 FY2022 | May 10, 2022 | -$0.50 | -$0.50 | +0.0% | — | — | — |
| ▼ Q1 FY2022 | Mar 22, 2022 | -$1.56 | -$15.71 | -907.0% | — | — | — |
| — Q3 FY2021 | Sep 30, 2021 | — | -$0.25 | — | — | — | — |
| — Q2 FY2021 | Jun 30, 2021 | — | -$0.19 | — | — | — | — |
| — Q1 FY2021 | Mar 31, 2021 | — | -$0.16 | — | — | — | — |
Q1 FY2023
Mar 28, 2023
EPS Actual
—
EPS Est.
-$0.55
EPS Surpr.
—
Revenue
—
Q4 FY2022
Nov 3, 2022Beat
EPS Actual
-$0.51
EPS Est.
-$0.61
EPS Surpr.
+16.4%
Revenue
—
Q3 FY2022
Aug 8, 2022Miss
EPS Actual
-$0.56
EPS Est.
-$0.50
EPS Surpr.
-12.0%
Revenue
—
Q2 FY2022
May 10, 2022
EPS Actual
-$0.50
EPS Est.
-$0.50
EPS Surpr.
+0.0%
Revenue
—
Q1 FY2022
Mar 22, 2022Miss
EPS Actual
-$15.71
EPS Est.
-$1.56
EPS Surpr.
-907.0%
Revenue
—
Q3 FY2021
Sep 30, 2021
EPS Actual
-$0.25
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2021
Jun 30, 2021
EPS Actual
-$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2021
Mar 31, 2021
EPS Actual
-$0.16
EPS Est.
—
EPS Surpr.
—
Revenue
—
No analyst estimates available for CINC.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q4 FY2022 | Nov 3, 2022 | +16.4% | $32.94 | $28.23 | -14.30% |
| ▼ Q3 FY2022 | Aug 8, 2022 | -12.0% | $23.45 | $35.00 | +49.25% |
| ▲ Q2 FY2022 | May 10, 2022 | +0.0% | $21.03 | $22.15 | +5.33% |
| ▼ Q1 FY2022 | Mar 22, 2022 | -907.0% | $14.82 | $15.77 | +6.41% |
| — Q3 FY2021 | Sep 30, 2021 | — | No price data | $16.00 | — |
| — Q2 FY2021 | Jun 30, 2021 | — | No price data | $16.00 | — |
| — Q1 FY2021 | Mar 31, 2021 | — | No price data | $16.00 | — |
| — Q4 FY2020 | Dec 31, 2020 | — | No price data | $16.00 | — |
Q4 FY2022-14.30%
Report Date
Nov 3, 2022
EPS Beat/Miss
+16.4%
Price Before
$32.94
Price After
$28.23
Q3 FY2022+49.25%
Report Date
Aug 8, 2022
EPS Beat/Miss
-12.0%
Price Before
$23.45
Price After
$35.00
Q2 FY2022+5.33%
Report Date
May 10, 2022
EPS Beat/Miss
+0.0%
Price Before
$21.03
Price After
$22.15
Q1 FY2022+6.41%
Report Date
Mar 22, 2022
EPS Beat/Miss
-907.0%
Price Before
$14.82
Price After
$15.77
Q3 FY2021—
Report Date
Sep 30, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$16.00
Q2 FY2021—
Report Date
Jun 30, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$16.00
Q1 FY2021—
Report Date
Mar 31, 2021
EPS Beat/Miss
—
Price Before
—
Price After
$16.00
Q4 FY2020—
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
—
Price After
$16.00
Avg Beat Reaction-4.49%
Avg Miss Reaction+27.83%
Beat Rate2 / 8 quarters
Largest Move+49.25% (Q3 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CINC ends December
CinCor Pharma, Inc. (CINC) most recently reported earnings on November 3, 2022 for Q4 FY2022, posting EPS of $-0.51 — beating the analyst consensus of $-0.61 by +16.4%. The next CINC earnings date is expected around September 1, 2026.
Each quarter, investors track CINC earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CINC revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CINC's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CINC earnings · 5 questionsCinCor Pharma, Inc.'s next earnings report is expected around September 1, 2026. CINC typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CINC historically reports after market close (AMC).
CINC earnings datewhen is CINC earningsCINC next earnings datewhen does CINC report earningsCINC earnings calendar
▸ Source: FMP · CinCor Pharma, Inc. SEC filings · US GAAP · CinCor Pharma, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026